197 related articles for article (PubMed ID: 34903206)
1. The prognostic and clinical significance of IFI44L aberrant downregulation in patients with oral squamous cell carcinoma.
Ou D; Wu Y
BMC Cancer; 2021 Dec; 21(1):1327. PubMed ID: 34903206
[TBL] [Abstract][Full Text] [Related]
2. The integration of differentially expressed genes based on multiple microarray datasets for prediction of the prognosis in oral squamous cell carcinoma.
Zhao Y; Huang J; Chen J
Bioengineered; 2021 Dec; 12(1):3309-3321. PubMed ID: 34224327
[TBL] [Abstract][Full Text] [Related]
3. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
[TBL] [Abstract][Full Text] [Related]
4. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Guo H; Li C; Su X; Huang X
Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
[No Abstract] [Full Text] [Related]
5. Identification and validation of seven RNA binding protein genes as a prognostic signature in oral cavity squamous cell carcinoma.
Huang Z; Lan T; Wang J; Chen Z; Zhang X
Bioengineered; 2021 Dec; 12(1):7248-7262. PubMed ID: 34585646
[TBL] [Abstract][Full Text] [Related]
6. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
Song D; Tian J; Han X; Li X
Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
[TBL] [Abstract][Full Text] [Related]
7. MKI67 an potential oncogene of oral squamous cell carcinoma via the high throughput technology.
Liu ZM; Bao Y; Li TK; Di YB; Song WJ
Medicine (Baltimore); 2022 Dec; 101(52):e32595. PubMed ID: 36596059
[TBL] [Abstract][Full Text] [Related]
8. Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma.
Zhang S; Wu X; Diao P; Wang C; Wang D; Li S; Wang Y; Cheng J
J Cell Physiol; 2020 May; 235(5):4804-4813. PubMed ID: 31637730
[TBL] [Abstract][Full Text] [Related]
9. Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions.
Carenzo A; Serafini MS; Roca E; Paderno A; Mattavelli D; Romani C; Saintigny P; Koljenović S; Licitra L; De Cecco L; Bossi P
Cells; 2020 Aug; 9(8):. PubMed ID: 32756466
[TBL] [Abstract][Full Text] [Related]
10. Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets.
Shen Y; Liu J; Zhang L; Dong S; Zhang J; Liu Y; Zhou H; Dong W
Biomed Res Int; 2019; 2019():7376034. PubMed ID: 31485443
[TBL] [Abstract][Full Text] [Related]
11. KRT84 is a potential tumor suppressor and good prognosis signature of oral squamous cell carcinoma.
Liu Y; Li R; Ren G
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32181476
[TBL] [Abstract][Full Text] [Related]
12. Identification of potential biomarkers and survival analysis for oral squamous cell carcinoma: A transcriptomic study.
de Paula Souza DPS; Dos Reis Pereira Queiroz L; de Souza MG; de Jesus SF; Gomes ESB; Vitorino RT; Santos SHS; Farias LC; de Paula AMB; D'Angelo MFSV; de Carvalho Fraga CA; Guimarães ALS
Oral Dis; 2023 Oct; 29(7):2658-2666. PubMed ID: 35796645
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
[No Abstract] [Full Text] [Related]
14. Weighted Gene Co-Expression Network Analysis Identifies Hub Genes Associated with Occurrence and Prognosis of Oral Squamous Cell Carcinoma.
Ge Y; Li W; Ni Q; He Y; Chu J; Wei P
Med Sci Monit; 2019 Sep; 25():7272-7288. PubMed ID: 31562292
[TBL] [Abstract][Full Text] [Related]
15. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
[TBL] [Abstract][Full Text] [Related]
16. A novel 4-gene signature model simultaneously predicting malignant risk of oral potentially malignant disorders and oral squamous cell carcinoma prognosis.
Zhang X; Yang M; Liu Y; Liu H; Yang J; Luo J; Zhou H
Arch Oral Biol; 2021 Sep; 129():105203. PubMed ID: 34252587
[TBL] [Abstract][Full Text] [Related]
17. Differential expression analysis for individual cancer samples based on robust within-sample relative gene expression orderings across multiple profiling platforms.
Guan Q; Chen R; Yan H; Cai H; Guo Y; Li M; Li X; Tong M; Ao L; Li H; Hong G; Guo Z
Oncotarget; 2016 Oct; 7(42):68909-68920. PubMed ID: 27634898
[TBL] [Abstract][Full Text] [Related]
18. Deregulation of extracellular matrix modeling with molecular prognostic markers revealed by transcriptome sequencing and validations in Oral Tongue squamous cell carcinoma.
Thangaraj SV; Shyamsundar V; Krishnamurthy A; Ramshankar V
Sci Rep; 2021 Jan; 11(1):250. PubMed ID: 33420101
[TBL] [Abstract][Full Text] [Related]
19. Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma.
Yang Z; Liang X; Fu Y; Liu Y; Zheng L; Liu F; Li T; Yin X; Qiao X; Xu X
EBioMedicine; 2019 Sep; 47():44-57. PubMed ID: 31409573
[TBL] [Abstract][Full Text] [Related]
20. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]